Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards - Jun 15, 2020

Abbott — Healthy Living Blog — Healthy Living Medical Supply

U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems

Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases

Landscape of Continuous Glucose Monitoring (CGM) and Integrated CGM: Accuracy Considerations

Improving Equitable Access to Continuous Glucose Monitors for Alabama's Children with Type 1 Diabetes: A Quality Improvement Project

Improving Equitable Access to Continuous Glucose Monitors for Alabama's Children with Type 1 Diabetes: A Quality Improvement Project

FreeStyle Libre 2 Continuous Glucose Monitor

The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference Berlin, Germany—February 20–23, 2019

FreeStyle Libre 2 Continuous Glucose Monitor

FDA OKs FreeStyle Libre 2 System for Adults and Children With Diabetes

Lindsy Delco (@ldelco) / X

Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards

Abbott — Healthy Living Blog — Healthy Living Medical Supply